Investigating the Role of Leukocyte Telomere Length in Treatment-Resistant Depression and in Response to Electroconvulsive Therapy
Authors:
- Claudia PisanuCPClaudia Pisanu
- Erika VitaliEVErika Vitali
- Anna MeloniAMAnna Meloni
- Donatella CongiuDCDonatella Congiu
- Giovanni SeverinoGSGiovanni Severino
- Raffaella ArdauRARaffaella Ardau
- Caterina ChillottiCCCaterina Chillotti
- Luigi TrabucchiLTLuigi Trabucchi
- Marco BortolomasiMBMarco Bortolomasi
- Massimo GennarelliMGMassimo Gennarelli
- Alessandra MinelliAMAlessandra Minelli
- Alessio SquassinaAlessio Squassina
Open Access
- 27 October 2021
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 11 (11) , 1100
Abstract
Psychiatric disorders seem to be characterized by premature cell senescence. However, controversial results have also been reported. In addition, the relationship between accelerated aging and treatment-resistance has scarcely been investigated. In the current study, we measured leukocyte telomere length (LTL) in 148 patients with treatment-resistant depression (TRD, 125 with major depressive disorder, MDD, and 23 with bipolar disorder, BD) treated with electroconvulsive therapy (ECT) and analyzed whether LTL was associated with different response profiles. We also compared LTL between patients with TRD and 335 non-psychiatric controls. For 107 patients for which genome-wide association data were available, we evaluated whether a significant overlap among genetic variants or genes associated with LTL and with response to ECT could be observed. LTL was negatively correlated with age (Spearman’s correlation coefficient = −0.25, p < 0.0001) and significantly shorter in patients with treatment-resistant MDD (Quade’s F = 35.18, p < 0.0001) or BD (Quade’s F = 20.84, p < 0.0001) compared to controls. Conversely, baseline LTL was not associated with response to ECT or remission. We did not detect any significant overlap between genetic variants or genes associated with LTL and response to ECT. Our results support previous findings suggesting premature cell senescence in patients with severe psychiatric disorders and suggest that LTL could not be a predictive biomarker of response to ECT.Keywords
Funding Information
- Fondo integrativo per la ricerca (Fir) (Year 2019 and 2020)
- Sardinian Regional Government (P.O.R. Sardegna F.S.E. - Operational Programme of the Autonomous Region of Sardinia, European Social Fund 2014-2020)
This publication has 101 references indexed in Scilit:
- Long-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeresTranslational Psychiatry, 2013
- Treatment of bipolar disorderThe Lancet, 2013
- Treatment-resistant depression: therapeutic trends, challenges, and future directionsPatient Preference and Adherence, 2012
- Refractoriness in Bipolar Disorder: Definitions and Evidence‐Based TreatmentCNS Neuroscience & Therapeutics, 2011
- Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey InitiativeArchives of General Psychiatry, 2011
- Telomere length of patients with major depression is shortened but independent from therapy and severity of the diseaseDepression and Anxiety, 2010
- Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)European Psychiatry, 2009
- Treatment of bipolar disorder: a complex treatment for a multi-faceted disorderAnnals of General Psychiatry, 2007
- The Revised Monoamine Theory of Depression: A Modulatory Role for Monoamines, Based on New Findings From Monoamine Depletion Experiments in HumansPharmacopsychiatry, 1996
- Recent advances in the cell biology of agingMechanisms of Ageing and Development, 1980